Sponsored by:
CVI Seminar Series
Academic Year 2011-2012
Mechanisms of the Acute Coronary Syndromes
October 26, 2011
4:00-5:00 PM
11-146 Translational Research Center
Peter Libby, MD
Chief, Division of Cardiovascular Medicine
Brigham and Women’s Hospital
Boston, MA
Target Audience
This program has been designed for University of Pennsylvania faculty members performing basic, translational and
clinical research as well as instructors, researchers, post doctoral researchers and per-doctoral trainees.
Educational Objectives
After completing this activity, participants should be able to:
 To identify state-of-the art translational cardiovascular research
 To consider training for careers as outstanding independent basic scientists and investigators
 To use multi-disciplinary approach in investigating key strategic areas of research
Accreditation
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for
Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation of Credit
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA
PRA Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in
the activity.
Acknowledgement of Commercial Support*
NONE
For more information, please contact
Nina Maschak
215-573-8002
maschak@mail.med.upenn.edu
Check your CME online at www.med.upenn.edu/cme
Disclosure of Relevant Financial Relationships and Unapproved Uses of Products
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the
content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial
interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this
purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in
CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice,
are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all
content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to
contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were
instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania and the peer reviewer(s)
Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial relationships with any
commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to
the content of this educational activity:
FACULTY NAME
JONATHAN A. EPSTEIN, MD
MARK L. KAHN, MD
KENNETH B. MARGULIES, MD
EDWARD E. MORRISEY, PHD
PRESENTER NAME
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of
this educational activity.
FACULTY NAME
Michael S. Parmacek, MD
Michael Acker, MD
Thomas P. Cappola, MD
Daniel Rader, MD
NAME OF COMMERCIAL INTEREST
NHLBi
Thoratec Corp
Abbott Laboratories & Celladon
Merck & Co, Novartis
Aegerion Pharma, Vascular Strategies
RELATIONSHIP
Scientific Advisor
Consultant
Research Grant
Consultant
Stock
PRESENTER NAME
Peter Libby, MD
NAME OF COMMERCIAL INTEREST
Amgen
RELATIONSHIP
Consultant
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USE